 | • レポートコード：20QY06-05447 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、口腔内崩壊錠のグローバル市場について種類別（抗精神病薬、抗癲癇薬、その他）、用途別（CNS疾患、消化器疾患、CVS疾患、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・口腔内崩壊錠市場の概要 ・世界の主要地域別口腔内崩壊錠市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の口腔内崩壊錠市場規模2015-2026：種類別（抗精神病薬、抗癲癇薬、その他） ・世界の口腔内崩壊錠市場規模2015-2026：用途別（CNS疾患、消化器疾患、CVS疾患、その他） ・口腔内崩壊錠の北米市場規模2015-2020 ・口腔内崩壊錠のヨーロッパ市場規模2015-2020 ・口腔内崩壊錠の中国市場規模2015-2020 ・口腔内崩壊錠の日本市場規模2015-2020 ・口腔内崩壊錠の東南アジア市場規模2015-2020 ・口腔内崩壊錠のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK、Otsuka、Mylan、Teva、Pfizer、Eli Lilly and Company、Merck、Eisai、AstraZeneca、Bristol-Myers Squibb、Conquer） ・口腔内崩壊錠の製造コスト分析 ・販売チャネル、流通業者、顧客 ・口腔内崩壊錠の市場動向・機会・課題 ・調査の結論 |
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.6% in 2018. and forecasts indicate a 54.2% market share for this segment by the end of the forecast period in 2025. North America is the largest consumption place, with a consumption market share nearly 44.99% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 33.84%, China is also an important sales region for the Orally Disintegrating Tablet.
Market Analysis and Insights: Global Orally Disintegrating Tablet Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Orally Disintegrating Tablet market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Orally Disintegrating Tablet industry.
Based on our recent survey, we have several different scenarios about the Orally Disintegrating Tablet YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 9681.2 million in 2019. The market size of Orally Disintegrating Tablet will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Orally Disintegrating Tablet Scope and Market Size
The global Orally Disintegrating Tablet market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orally Disintegrating Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Orally Disintegrating Tablet market is segmented into
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segment by Application, the Orally Disintegrating Tablet market is segmented into
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
The Orally Disintegrating Tablet market is analysed and market size information is provided by regions (countries). Segment by Application, the Orally Disintegrating Tablet market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Orally Disintegrating Tablet Market Share Analysis
Orally Disintegrating Tablet market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Orally Disintegrating Tablet business, the date to enter into the Orally Disintegrating Tablet market, Orally Disintegrating Tablet product introduction, recent developments, etc.
The major vendors covered:
GSK
Otsuka
Mylan
Teva
Pfizer
Eli Lilly and Company
Merck
Eisai
AstraZeneca
Bristol-Myers Squibb
Conquer
1 Orally Disintegrating Tablet Market Overview
1.1 Orally Disintegrating Tablet Product Scope
1.2 Orally Disintegrating Tablet Segment by Type
1.2.1 Global Orally Disintegrating Tablet Sales by Type (2020-2026)
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Orally Disintegrating Tablet Segment by Application
1.3.1 Global Orally Disintegrating Tablet Sales Comparison by Application (2020-2026)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Orally Disintegrating Tablet Market Estimates and Forecasts (2015-2026)
1.4.1 Global Orally Disintegrating Tablet Sales Growth Rate (2015-2026)
1.4.2 Global Orally Disintegrating Tablet Revenue and Growth Rate (2015-2026)
1.4.3 Global Orally Disintegrating Tablet Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Orally Disintegrating Tablet Industry Impact
1.5.1 How the Covid-19 is Affecting the Orally Disintegrating Tablet Industry
1.5.1.1 Orally Disintegrating Tablet Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Orally Disintegrating Tablet Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Orally Disintegrating Tablet Players to Combat Covid-19 Impact
2 Orally Disintegrating Tablet Estimate and Forecast by Region
2.1 Global Orally Disintegrating Tablet Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Orally Disintegrating Tablet Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Orally Disintegrating Tablet Sales Market Share by Region (2015-2020)
2.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Region (2015-2020)
2.3 Global Orally Disintegrating Tablet Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Orally Disintegrating Tablet Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Orally Disintegrating Tablet Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Orally Disintegrating Tablet Estimates and Projections (2015-2026)
2.4.2 Europe Orally Disintegrating Tablet Estimates and Projections (2015-2026)
2.4.3 China Orally Disintegrating Tablet Estimates and Projections (2015-2026)
2.4.4 Japan Orally Disintegrating Tablet Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Orally Disintegrating Tablet Estimates and Projections (2015-2026)
2.4.6 India Orally Disintegrating Tablet Estimates and Projections (2015-2026)
3 Global Orally Disintegrating Tablet Competition Landscape by Players
3.1 Global Top Orally Disintegrating Tablet Players by Sales (2015-2020)
3.2 Global Top Orally Disintegrating Tablet Players by Revenue (2015-2020)
3.3 Global Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orally Disintegrating Tablet as of 2019)
3.4 Global Orally Disintegrating Tablet Average Price by Company (2015-2020)
3.5 Manufacturers Orally Disintegrating Tablet Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Orally Disintegrating Tablet Players (Opinion Leaders)
4 Global Orally Disintegrating Tablet Market Size by Type
4.1 Global Orally Disintegrating Tablet Historic Market Review by Type (2015-2020)
4.1.1 Global Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
4.1.2 Global Orally Disintegrating Tablet Revenue Market Share by Type (2015-2020)
4.1.3 Global Orally Disintegrating Tablet Price by Type (2014-2020)
4.2 Global Orally Disintegrating Tablet Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Orally Disintegrating Tablet Sales Forecast by Type (2021-2026)
4.2.2 Global Orally Disintegrating Tablet Revenue Forecast by Type (2021-2026)
4.2.3 Global Orally Disintegrating Tablet Price Forecast by Type (2021-2026)
5 Global Orally Disintegrating Tablet Market Size by Application
5.1 Global Orally Disintegrating Tablet Historic Market Review by Application (2015-2020)
5.1.1 Global Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
5.1.2 Global Orally Disintegrating Tablet Revenue Market Share by Application (2015-2020)
5.1.3 Global Orally Disintegrating Tablet Price by Application (2015-2020)
5.2 Global Orally Disintegrating Tablet Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Orally Disintegrating Tablet Sales Forecast by Application (2021-2026)
5.2.2 Global Orally Disintegrating Tablet Revenue Forecast by Application (2021-2026)
5.2.3 Global Orally Disintegrating Tablet Price Forecast by Application (2021-2026)
3 North America Orally Disintegrating Tablet Market Facts & Figures
3.2 North America Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
3.3 North America Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
3.4 North America Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
4 Europe Orally Disintegrating Tablet Market Facts & Figures
4.2 Europe Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
4.3 Europe Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
4.4 Europe Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
5 China Orally Disintegrating Tablet Market Facts & Figures
5.2 China Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
5.3 China Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
5.4 China Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
6 Japan Orally Disintegrating Tablet Market Facts & Figures
6.2 Japan Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
6.3 Japan Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
6.4 Japan Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
7 Southeast Asia Orally Disintegrating Tablet Market Facts & Figures
7.2 Southeast Asia Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
8 India Orally Disintegrating Tablet Market Facts & Figures
8.2 India Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
8.3 India Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
8.4 India Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Orally Disintegrating Tablet Business
12.1 GSK
12.1.1 GSK Orally Disintegrating Tablet Corporation Information
12.1.2 GSK Orally Disintegrating Tablet Business Overview and Total Revenue
12.1.3 GSK Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Orally Disintegrating Tablet Products Offered
12.1.5 GSK Recent Development
12.2 Otsuka
12.2.1 Otsuka Orally Disintegrating Tablet Corporation Information
12.2.2 Otsuka Orally Disintegrating Tablet Business Overview and Total Revenue
12.2.3 Otsuka Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Otsuka Orally Disintegrating Tablet Products Offered
12.2.5 Otsuka Recent Development
12.3 Mylan
12.3.1 Mylan Orally Disintegrating Tablet Corporation Information
12.3.2 Mylan Orally Disintegrating Tablet Business Overview and Total Revenue
12.3.3 Mylan Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Orally Disintegrating Tablet Products Offered
12.3.5 Mylan Recent Development
12.4 Teva
12.4.1 Teva Orally Disintegrating Tablet Corporation Information
12.4.2 Teva Orally Disintegrating Tablet Business Overview and Total Revenue
12.4.3 Teva Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teva Orally Disintegrating Tablet Products Offered
12.4.5 Teva Recent Development
12.5 Pfizer
12.5.1 Pfizer Orally Disintegrating Tablet Corporation Information
12.5.2 Pfizer Orally Disintegrating Tablet Business Overview and Total Revenue
12.5.3 Pfizer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Orally Disintegrating Tablet Products Offered
12.5.5 Pfizer Recent Development
12.6 Eli Lilly and Company
12.6.1 Eli Lilly and Company Orally Disintegrating Tablet Corporation Information
12.6.2 Eli Lilly and Company Orally Disintegrating Tablet Business Overview and Total Revenue
12.6.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly and Company Orally Disintegrating Tablet Products Offered
12.6.5 Eli Lilly and Company Recent Development
12.7 Merck
12.7.1 Merck Orally Disintegrating Tablet Corporation Information
12.7.2 Merck Orally Disintegrating Tablet Business Overview and Total Revenue
12.7.3 Merck Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck Orally Disintegrating Tablet Products Offered
12.7.5 Merck Recent Development
12.8 Eisai
12.8.1 Eisai Orally Disintegrating Tablet Corporation Information
12.8.2 Eisai Orally Disintegrating Tablet Business Overview and Total Revenue
12.8.3 Eisai Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eisai Orally Disintegrating Tablet Products Offered
12.8.5 Eisai Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Orally Disintegrating Tablet Corporation Information
12.9.2 AstraZeneca Orally Disintegrating Tablet Business Overview and Total Revenue
12.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.9.4 AstraZeneca Orally Disintegrating Tablet Products Offered
12.9.5 AstraZeneca Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Orally Disintegrating Tablet Corporation Information
12.10.2 Bristol-Myers Squibb Orally Disintegrating Tablet Business Overview and Total Revenue
12.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Products Offered
12.10.5 Bristol-Myers Squibb Recent Development
12.11 Conquer
12.11.1 Conquer Orally Disintegrating Tablet Corporation Information
12.11.2 Conquer Orally Disintegrating Tablet Business Overview and Total Revenue
12.11.3 Conquer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Conquer Orally Disintegrating Tablet Products Offered
12.11.5 Conquer Recent Development
13 Orally Disintegrating Tablet Manufacturing Cost Analysis
13.1 Orally Disintegrating Tablet Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Orally Disintegrating Tablet
13.4 Orally Disintegrating Tablet Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Orally Disintegrating Tablet Distributors List
14.3 Orally Disintegrating Tablet Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Orally Disintegrating Tablet Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Orally Disintegrating Tablet Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Orally Disintegrating Tablet Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Orally Disintegrating Tablet Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Orally Disintegrating Tablet Players to Combat Covid-19 Impact
Table 8. Global Market Orally Disintegrating Tablet Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Orally Disintegrating Tablet Sales (M Units) by Region (2015-2020)
Table 10. Global Orally Disintegrating Tablet Sales Market Share by Region (2015-2020)
Table 11. Global Orally Disintegrating Tablet Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Orally Disintegrating Tablet Revenue Share by Region (2015-2020)
Table 13. Global Orally Disintegrating Tablet Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Orally Disintegrating Tablet Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Orally Disintegrating Tablet Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Orally Disintegrating Tablet Revenue Share Forecast by Region (2021-2026)
Table 17. Global Orally Disintegrating Tablet (M Units) of Key Companies (2015-2020)
Table 18. Global Orally Disintegrating Tablet Sales Share by Company (2015-2020)
Table 19. Global Orally Disintegrating Tablet Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Orally Disintegrating Tablet Revenue Share by Company (2015-2020)
Table 21. Global Orally Disintegrating Tablet by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orally Disintegrating Tablet as of 2019)
Table 22. Global Orally Disintegrating Tablet Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Orally Disintegrating Tablet Manufacturing Sites and Area Served
Table 24. Manufacturers Orally Disintegrating Tablet Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Orally Disintegrating Tablet Players
Table 27. Global Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 28. Global Orally Disintegrating Tablet Sales Share by Type (2015-2020)
Table 29. Global Orally Disintegrating Tablet Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Orally Disintegrating Tablet Price (M Units) by Type (2015-2020)
Table 31. Global Orally Disintegrating Tablet Sales Share by Type (2021-2026)
Table 32. Global Orally Disintegrating Tablet Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Orally Disintegrating Tablet Revenue Share by Type (2021-2026)
Table 34. Global Orally Disintegrating Tablet Price (M Units) by Type (2021-2026)
Table 35. Global Orally Disintegrating Tablet Sales (M Units) by Application (2015-2020)
Table 36. Global Orally Disintegrating Tablet Sales Share by Application (2015-2020)
Table 37. Global Orally Disintegrating Tablet Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Orally Disintegrating Tablet Price (M Units) by Application (2015-2020)
Table 39. Global Orally Disintegrating Tablet Sales (M Units) by Application (2021-2026)
Table 40. Global Orally Disintegrating Tablet Sales Share by Application (2021-2026)
Table 41. Global Orally Disintegrating Tablet Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Orally Disintegrating Tablet Revenue Share by Application (2021-2026)
Table 43. Global Orally Disintegrating Tablet Price (M Units) by Application (2021-2026)
Table 44. United States Orally Disintegrating Tablet Sales (M Units) by Company (2015-2020)
Table 45. United States Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
Table 46. United States Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 47. United States Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
Table 48. United States Orally Disintegrating Tablet Sales (M Units) by Application (2015-2020)
Table 49. United States Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
Table 50. Europe Orally Disintegrating Tablet Sales (M Units) by Company (2015-2020)
Table 51. Europe Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
Table 52. Europe Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 53. Europe Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
Table 54. Europe Orally Disintegrating Tablet Sales (M Units) by Application (2015-2020)
Table 55. Europe Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
Table 56. China Orally Disintegrating Tablet Sales (M Units) by Company (2015-2020)
Table 57. China Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
Table 58. China Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 59. China Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
Table 60. China Orally Disintegrating Tablet Sales (M Units) by Application (2015-2020)
Table 61. China Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
Table 62. Japan Orally Disintegrating Tablet Sales (M Units) by Company (2015-2020)
Table 63. Japan Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
Table 64. Japan Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 65. Japan Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
Table 66. Japan Orally Disintegrating Tablet Sales (M Units) by Application (2015-2020)
Table 67. Japan Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Orally Disintegrating Tablet Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
Table 74. India Orally Disintegrating Tablet Sales (M Units) by Company (2015-2020)
Table 75. India Orally Disintegrating Tablet Sales Market Share by Company (2015-2020)
Table 76. India Orally Disintegrating Tablet Sales (M Units) by Type (2015-2020)
Table 77. India Orally Disintegrating Tablet Sales Market Share by Type (2015-2020)
Table 78. India Orally Disintegrating Tablet Sales (M Units) by Application (2015-2020)
Table 79. India Orally Disintegrating Tablet Sales Market Share by Application (2015-2020)
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GSK Orally Disintegrating Tablet Product
Table 84. GSK Recent Development
Table 85. Otsuka Corporation Information
Table 86. Otsuka Description and Business Overview
Table 87. Otsuka Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Otsuka Orally Disintegrating Tablet Product
Table 89. Otsuka Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Mylan Orally Disintegrating Tablet Product
Table 94. Mylan Recent Development
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Teva Orally Disintegrating Tablet Product
Table 99. Teva Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pfizer Orally Disintegrating Tablet Product
Table 104. Pfizer Recent Development
Table 105. Eli Lilly and Company Corporation Information
Table 106. Eli Lilly and Company Description and Business Overview
Table 107. Eli Lilly and Company Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Eli Lilly and Company Orally Disintegrating Tablet Product
Table 109. Eli Lilly and Company Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Merck Orally Disintegrating Tablet Product
Table 114. Merck Recent Development
Table 115. Eisai Corporation Information
Table 116. Eisai Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Eisai Description and Business Overview
Table 118. Eisai Orally Disintegrating Tablet Product
Table 119. Eisai Recent Development
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. AstraZeneca Description and Business Overview
Table 123. AstraZeneca Orally Disintegrating Tablet Product
Table 124. AstraZeneca Recent Development
Table 125. Bristol-Myers Squibb Corporation Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Bristol-Myers Squibb Orally Disintegrating Tablet Product
Table 129. Bristol-Myers Squibb Recent Development
Table . Conquer Corporation Information
Table . Conquer Description and Business Overview
Table . Conquer Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Conquer Orally Disintegrating Tablet Product
Table . Conquer Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Orally Disintegrating Tablet Distributors List
Table 138. Orally Disintegrating Tablet Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Orally Disintegrating Tablet Product Picture
Figure 2. Global Orally Disintegrating Tablet Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Orally Disintegrating Tablet Market Share by Application in 2020 & 2026
Figure 6. CNS Diseases Examples
Figure 7. Gastrointestinal Diseases Examples
Figure 8. CVS Diseases Examples
Figure 9. Other Examples
Figure 10. Global Orally Disintegrating Tablet Sales (M Units) Growth Rate (2015-2026)
Figure 11. Global Orally Disintegrating Tablet Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Orally Disintegrating Tablet Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Orally Disintegrating Tablet Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Orally Disintegrating Tablet Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Orally Disintegrating Tablet Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Orally Disintegrating Tablet Sales (M Units) Growth Rate (2015-2026)
Figure 17. Europe Orally Disintegrating Tablet Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Orally Disintegrating Tablet Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Orally Disintegrating Tablet Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Orally Disintegrating Tablet Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Orally Disintegrating Tablet Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Orally Disintegrating Tablet Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Orally Disintegrating Tablet Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Orally Disintegrating Tablet Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Orally Disintegrating Tablet Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Orally Disintegrating Tablet Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Orally Disintegrating Tablet Players Market Share by Revenue in Orally Disintegrating Tablet 2015 & 2019
Figure 28. Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Orally Disintegrating Tablet Revenue Share by Type (2015-2020)
Figure 30. Global Orally Disintegrating Tablet Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Orally Disintegrating Tablet Revenue Share by Application (2015-2020)
Figure 32. Global Orally Disintegrating Tablet Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Orally Disintegrating Tablet Sales Market Share by Type in 2019
Figure 34. United States Orally Disintegrating Tablet Sales Market Share by Type in 2019
Figure 35. Europe Orally Disintegrating Tablet Sales Market Share by Company in 2019
Figure 36. Europe Orally Disintegrating Tablet Sales Market Share by Type in 2019
Figure 37. Europe Orally Disintegrating Tablet Sales Market Share by Application in 2019
Figure 38. China Orally Disintegrating Tablet Sales Market Share by Company in 2019
Figure 39. China Orally Disintegrating Tablet Sales Market Share by Type in 2019
Figure 40. China Orally Disintegrating Tablet Sales Market Share by Application in 2019
Figure 41. Japan Orally Disintegrating Tablet Sales Market Share by Company in 2019
Figure 42. Japan Orally Disintegrating Tablet Sales Market Share by Type in 2019
Figure 43. Japan Orally Disintegrating Tablet Sales Market Share by Application in 2019
Figure 44. Southeast Asia Orally Disintegrating Tablet Sales Market Share by Company in 2019
Figure 45. Southeast Asia Orally Disintegrating Tablet Sales Market Share by Type in 2019
Figure 46. Southeast Asia Orally Disintegrating Tablet Sales Market Share by Application in 2019
Figure 47. India Orally Disintegrating Tablet Sales Market Share by Company in 2019
Figure 48. India Orally Disintegrating Tablet Sales Market Share by Type in 2019
Figure 49. India Orally Disintegrating Tablet Sales Market Share by Application in 2019
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Conquer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Orally Disintegrating Tablet
Figure 63. Manufacturing Process Analysis of Orally Disintegrating Tablet
Figure 64. Orally Disintegrating Tablet Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
口腔内崩壊錠の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Orally Disintegrating Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Orally Disinteg…- 崩壊剤の世界市場レポート2020 The disintegrant refers to a substance which can rapidly break up a tablet into fine particles in a gastrointestinal fluid, thereby allowing the functional ingredient to rapidly dissolve and absorb and function. Most of the disintegrants have good water absorption and swelling properties, thereby ac…
- エベロリムス錠の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Everolimus Tablet market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Everolimus Tablet market re…
- 発泡錠の世界市場レポート2020 Effervescent tablets are designed to break in contact with liquid such as water or juice, often causing the tablet to dissolve into a solution. Market Analysis and Insights: Global Effervescent Tablet Market The global Effervescent Tablet market was valued at US$ xx million in 2019 and will reach US…
- マルチタッチスクリーンタブレットPCの世界市場レポート2020 In computing, multi-touch is technology which enables a trackpad or touchscreen to recognize more than one or more than two points of contact with the surface. Multi-touch technology is based on the capacitive touch technology instead of resistive touch technology. This technology has given an alter…